Search All UT System Experts

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

Kamal K.S. Abbi, Syed M. Rizvi, Jeffrey Sivik, Subramanian Thyagarajan, Thomas Loughran, Joseph J. Drabick

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature'. Together they form a unique fingerprint.